Chloé Prunier

452 total citations
12 papers, 230 citations indexed

About

Chloé Prunier is a scholar working on Molecular Biology, Oncology and Biophysics. According to data from OpenAlex, Chloé Prunier has authored 12 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Biophysics. Recurrent topics in Chloé Prunier's work include Cancer Cells and Metastasis (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Chloé Prunier is often cited by papers focused on Cancer Cells and Metastasis (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Chloé Prunier collaborates with scholars based in Netherlands, France and India. Chloé Prunier's co-authors include Laila Ritsma, Reuben Kapur, Renaud Prudent, Laurence Lafanéchère, Karin Sadoul, Peter ten Dijke, D.A. Baker, Nienke Vrisekoop, Jean‐Luc Coll and Marc Billaud and has published in prestigious journals such as Cancer Research, Oncotarget and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Chloé Prunier

12 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloé Prunier Netherlands 7 106 80 75 37 27 12 230
Galina Shagieva Russia 10 126 1.2× 49 0.6× 98 1.3× 37 1.0× 17 0.6× 16 253
Jenny Tadros United States 5 121 1.1× 110 1.4× 80 1.1× 36 1.0× 72 2.7× 6 252
Gretchen M. Alicea United States 7 155 1.5× 143 1.8× 33 0.4× 35 0.9× 59 2.2× 8 257
Emanuel Salazar-Cavazos United States 4 194 1.8× 129 1.6× 33 0.4× 21 0.6× 55 2.0× 8 324
Zahra Erami United Kingdom 9 168 1.6× 48 0.6× 83 1.1× 67 1.8× 29 1.1× 9 295
Ramon M. Cabrera United States 4 143 1.3× 147 1.8× 71 0.9× 79 2.1× 27 1.0× 4 329
Filipe V. Almeida United Kingdom 3 88 0.8× 90 1.1× 42 0.6× 24 0.6× 50 1.9× 5 180
Romana Ranftl United Kingdom 3 150 1.4× 82 1.0× 84 1.1× 43 1.2× 32 1.2× 4 227
Hoang-Lan Nguyen United States 7 247 2.3× 89 1.1× 194 2.6× 74 2.0× 19 0.7× 8 386
Jenna A. Mosier United States 9 120 1.1× 115 1.4× 78 1.0× 97 2.6× 19 0.7× 11 296

Countries citing papers authored by Chloé Prunier

Since Specialization
Citations

This map shows the geographic impact of Chloé Prunier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé Prunier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé Prunier more than expected).

Fields of papers citing papers by Chloé Prunier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé Prunier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé Prunier. The network helps show where Chloé Prunier may publish in the future.

Co-authorship network of co-authors of Chloé Prunier

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé Prunier. A scholar is included among the top collaborators of Chloé Prunier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé Prunier. Chloé Prunier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Prunier, Chloé, et al.. (2024). Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model. Anticancer Research. 44(3). 941–951. 4 indexed citations
3.
Morin, Aurélie, Chloé Prunier, Virginie Magnone, et al.. (2022). Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched. Pharmaceutics. 14(5). 988–988. 2 indexed citations
4.
Wang, Yan, et al.. (2022). PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo. Cancers. 14(13). 3095–3095. 9 indexed citations
5.
Prunier, Chloé, Ania Alay, Amina F.A.S. Teunisse, et al.. (2021). Breast cancer dormancy is associated with a 4NG1 state and not senescence. npj Breast Cancer. 7(1). 140–140. 12 indexed citations
6.
Prunier, Chloé, D.A. Baker, Peter ten Dijke, & Laila Ritsma. (2018). TGF-β Family Signaling Pathways in Cellular Dormancy. Trends in cancer. 5(1). 66–78. 57 indexed citations
7.
Prunier, Chloé, et al.. (2018). PO-185 Towards dynamic targeting of TGF-β in metastatic melanoma using intravital microscopy. ESMO Open. 3. A93–A94. 1 indexed citations
8.
Grinsven, Erinke van, Chloé Prunier, Nienke Vrisekoop, & Laila Ritsma. (2017). Two-Photon Intravital Microscopy Animal Preparation Protocol to Study Cellular Dynamics in Pathogenesis. Methods in molecular biology. 1563. 51–71. 4 indexed citations
9.
Prunier, Chloé, et al.. (2017). Procedures and applications of long-term intravital microscopy. Methods. 128. 52–64. 19 indexed citations
10.
Prunier, Chloé, Renaud Prudent, Reuben Kapur, Karin Sadoul, & Laurence Lafanéchère. (2017). LIM kinases: cofilin and beyond. Oncotarget. 8(25). 41749–41763. 82 indexed citations
11.
Prunier, Chloé, Véronique Josserand, Julien Vollaire, et al.. (2016). LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers. Cancer Research. 76(12). 3541–3552. 27 indexed citations
12.
Prunier, Chloé, et al.. (2011). Aging and photo-aging DNA repair phenotype of skin cells—Evidence toward an effect of chronic sun-exposure. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 736(1-2). 48–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026